Shanghai Junshi Biosciences Co., Ltd. (688180.SS)
CNY 29.19
(-0.92%)
CNY 29.19
(-0.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.45 Billion CNY | 5.9% |
| 2022 | -2.67 Billion CNY | -289.83% |
| 2021 | -685.33 Million CNY | 59.18% |
| 2020 | -1.67 Billion CNY | -119.65% |
| 2019 | -764.44 Million CNY | -11.74% |
| 2018 | -684.12 Million CNY | -97.87% |
| 2017 | -345.73 Million CNY | -133.12% |
| 2016 | -148.31 Million CNY | -82.89% |
| 2015 | -81.09 Million CNY | -91.77% |
| 2014 | -42.28 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -335.28 Million CNY | -4.0% |
| 2024 Q2 | -322.38 Million CNY | -2.31% |
| 2024 Q1 | -315.11 Million CNY | 66.53% |
| 2023 Q1 | -677.87 Million CNY | 25.43% |
| 2023 FY | -2.51 Billion CNY | 5.9% |
| 2023 Q4 | -941.57 Million CNY | -223.21% |
| 2023 Q3 | -291.31 Million CNY | 42.3% |
| 2023 Q2 | -504.86 Million CNY | 25.52% |
| 2022 FY | -2.67 Billion CNY | -289.83% |
| 2022 Q4 | -909.03 Million CNY | -16.36% |
| 2022 Q3 | -781.23 Million CNY | -20.58% |
| 2022 Q1 | -392.04 Million CNY | -52.8% |
| 2022 Q2 | -647.91 Million CNY | -65.27% |
| 2021 FY | -685.33 Million CNY | 59.18% |
| 2021 Q1 | 446.56 Million CNY | 174.19% |
| 2021 Q2 | -467.76 Million CNY | -204.75% |
| 2021 Q3 | -407.58 Million CNY | 12.87% |
| 2021 Q4 | -256.57 Million CNY | 37.05% |
| 2020 Q1 | -214.21 Million CNY | 31.13% |
| 2020 Q3 | -496.15 Million CNY | -29.63% |
| 2020 FY | -1.67 Billion CNY | -119.65% |
| 2020 Q2 | -382.75 Million CNY | -78.68% |
| 2020 Q4 | -601.91 Million CNY | -21.32% |
| 2019 Q4 | -311.04 Million CNY | -63.01% |
| 2019 Q2 | -97.95 Million CNY | 52.75% |
| 2019 Q1 | -207.29 Million CNY | 20.8% |
| 2019 FY | -764.44 Million CNY | -11.74% |
| 2019 Q3 | -190.8 Million CNY | -94.8% |
| 2018 Q3 | -159.31 Million CNY | 9.98% |
| 2018 FY | -684.12 Million CNY | -97.87% |
| 2018 Q2 | -176.97 Million CNY | -93.7% |
| 2018 Q1 | -91.36 Million CNY | 29.84% |
| 2018 Q4 | -261.73 Million CNY | -64.29% |
| 2017 Q1 | -73.12 Million CNY | -33.07% |
| 2017 FY | -345.73 Million CNY | -133.12% |
| 2017 Q4 | -130.21 Million CNY | -81.5% |
| 2017 Q3 | -71.74 Million CNY | 2.28% |
| 2017 Q2 | -73.42 Million CNY | -0.4% |
| 2016 Q4 | -54.95 Million CNY | 1.91% |
| 2016 FY | -148.31 Million CNY | -82.89% |
| 2016 Q3 | -56.02 Million CNY | -119.69% |
| 2016 Q2 | -25.5 Million CNY | 0.0% |
| 2016 Q1 | -25.5 Million CNY | 10.09% |
| 2015 Q2 | -12.17 Million CNY | 0.0% |
| 2015 Q3 | -28.36 Million CNY | -132.91% |
| 2015 FY | -81.09 Million CNY | -91.77% |
| 2015 Q1 | -12.17 Million CNY | 16.67% |
| 2015 Q4 | -28.36 Million CNY | 0.0% |
| 2014 Q2 | -6.52 Million CNY | 0.0% |
| 2014 Q4 | -14.61 Million CNY | 0.0% |
| 2014 FY | -42.28 Million CNY | 0.0% |
| 2014 Q3 | -14.61 Million CNY | -123.93% |
| 2014 Q1 | -6.52 Million CNY | 0.0% |